Cutera (NASDAQ:CUTR) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Cutera (NASDAQ:CUTR) in a report issued on Monday. The brokerage issued a sell rating on the medical device company’s stock.

Cutera Trading Down 63.9 %

CUTR opened at $0.04 on Monday. Cutera has a 12 month low of $0.09 and a 12 month high of $2.88. The business’s 50-day moving average price is $0.06 and its 200-day moving average price is $0.31. The company has a market cap of $787,254.00, a P/E ratio of -0.01 and a beta of 1.36.

Institutional Investors Weigh In On Cutera

A hedge fund recently bought a new stake in Cutera stock. Sculptor Capital LP bought a new position in shares of Cutera, Inc. (NASDAQ:CUTR) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 166,000 shares of the medical device company’s stock, valued at approximately $59,000. Sculptor Capital LP owned 0.82% of Cutera at the end of the most recent quarter. 90.70% of the stock is owned by institutional investors and hedge funds.

About Cutera

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.